Retinal cell type-specific prevention of ischemia-induced damages by LPS-TLR4 signaling through microglia

Journal of Neurochemistry

Volumn 126, Issue 2, 2013, Pages 243-260

  Halder, Sebok K ^a   Matsunaga, Hayato ^a   Ishii, Ken J ^b   Akira, Shizuo ^b   Miyake, Kensuke ^c   Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

ischemia; lipopolysacharide; microglia; neuroprotection; toll like receptor 4

Indexed keywords

LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL MIGRATION; CELL PROLIFERATION; CELL SPECIFICITY; CONTROLLED STUDY; ISCHEMIC PRECONDITIONING; MALE; MICROGLIA; MOUSE; NONHUMAN; PHOTORECEPTOR CELL; PRIORITY JOURNAL; RETINA AMACRINE CELL; RETINA BIPOLAR GANGLION CELL; RETINA CELL; RETINA GANGLION CELL; RETINA ISCHEMIA; SIGNAL TRANSDUCTION;

ISCHEMIA; LIPOPOLYSACHARIDE; MICROGLIA; NEUROPROTECTION; TOLL-LIKE RECEPTOR 4;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTRORETINOGRAPHY; EYE PROTEINS; GENE EXPRESSION REGULATION; ISCHEMIA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MINOCYCLINE; RETINA; RETINAL DISEASES; SIGNAL TRANSDUCTION; TIME FACTORS; TOLL-LIKE RECEPTOR 4;

MUS;

EID: 84879944618     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12262     Document Type: Article

References (88)

1. Akashi S., Saitoh S., Wakabayashi Y., et al,. (2003) Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J. Exp. Med. 198, 1035-1042.
2. Akashi-Takamura S., Furuta T., Takahashi K., Tanimura N., Kusumoto Y., Kobayashi T., Saitoh S., Adachi Y., Doi T., and, Miyake K., (2006) Agonistic antibody to TLR4/MD-2 protects mice from acute lethal hepatitis induced by TNF-alpha. J. Immunol. 176, 4244-4251.
3. Arumugam T. V., Chan S. L., Jo D. G., et al,. (2006) Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke. Nat. Med. 12, 621-623.
4. Bastide M., Gele P., Petrault O., Pu Q., Caliz A., Robin E., Deplanque D., Duriez P., and, Bordet R., (2003) Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance. J. Cereb. Blood Flow Metab. 2, 399-405.
5. Bernstein S. L., Guo Y., Kelman S. E., Flower R. W., and, Johnson M. A., (2003) Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest. Ophthalmol. Vis. Sci. 44, 4153-4162.
6. Blum D., Chtarto A., Tenenbaum L., Brotchi J., and, Levivier M., (2004) Clinical potential of minocycline for neurodegenerative disorders. Neurobiol. Dis. 17, 359-366.
7. Broad A., Kirby J. A., and, Jones D. E., (2007) Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta production. Immunology 120, 103-111.
8. Bsibsi M., Ravid R., Gveric D., and, van Noort J. M., (2002) Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61, 1013-1021.
9. Buckingham B. P., Inman D. M., Lambert W., Oglesby E., Calkins D. J., Steele M. R., Vetter M. L., Marsh-Armstrong N., and, Horner P. J., (2008) Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J. Neurosci. 28, 2735-2744.
10. Bye N., Habgood M. D., Callaway J. K., Malakooti N., Potter A., Kossmann T., and, Morganti-Kossmann M. C., (2007) Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp. Neurol. 204, 220-233.
11. Cao C. X., Yang Q. W., Lv F. L., Cui J., Fu H. B., and, Wang J. Z., (2007) Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem. Biophys. Res. Commun. 353, 509-514.
12. Caso J. R., Pradillo J. M., Hurtado O., Lorenzo P., Moro M. A., and, Lizasoain I., (2007) Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115, 1599-1608.
13. Cervia D., and, Casini G., (2012) Recent advances in cellular and molecular aspects of mammalian retinal ischemia. World J. Pharmacol. 1, 30-43.
14. Chen Z., Jalabi W., Shpargel K. B., Farabaugh K. T., Dutta R., Yin X., Kidd G. J., Bergmann C. C., Stohlman S. A., and, Trapp B. D., (2012) Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J. Neurosci. 32, 11706-11715.
15. Danton G. H., and, Dietrich W. D., (2003) Inflammatory mechanisms after ischemia and stroke. J. Neuropathol. Exp. Neurol. 62, 127-136.
16. Denes A., Vidyasagar R., Feng J., Narvainen J., McColl B. W., Kauppinen R. A., and, Allan S. M., (2007) Proliferating resident microglia after focal cerebral ischaemia in mice. J. Cereb. Blood Flow Metab. 27, 1941-1953.
17. Du Y., Ma Z., Lin S., et al,. (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl Acad. Sci. USA 98, 14669-14674.
18. Dvoriantchikova G., Barakat D. J., Hernandez E., Shestopalov V. I., and, Ivanov D., (2010) Toll-like receptor 4 contributes to retinal ischemia/reperfusion Injury. Mol. Vis. 16, 1907-1912.
19. Fan L. W., Pang Y., Lin S., Rhodes P. G., and, Cai Z., (2005) Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neuroscience 133, 159-168.
20. Fujita R., Ueda M., Fujiwara K., and, Ueda H., (2009) Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition. Cell Death Differ. 16, 349-358.
21. Guha M., and, Mackman N., (2001) LPS induction of gene expression in human monocytes. Cell. Signal. 13, 85-94.
22. Halder S. K., Matsunaga H., and, Ueda H., (2012) Neuron-specific non-classical release of prothymosin alpha: a novel neuroprotective damage-associated molecular patterns. J. Neurochem. 123, 262-275.
23. Halder S. K., Matsunaga H., Yamaguchi H., and, Ueda H., (2013) Novel neuroprotective action of prothymosin alpha-derived peptide against retinal and brain ischemic damages. J. Neurochem. doi: 10.1111/jnc.12132 (in press).
24. Hernandez M., Rodriguez F. D., Sharma S. C., and, Vecino E., (2009) Immunohistochemical changes in rat retinas at various time periods of elevated intraocular pressure. Mol. Vis. 15, 2696-2709.
25. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., and, Akira S., (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749-3752.
26. Hua F., Ma J., Ha T., et al,. (2007) Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J. Neuroimmunol. 190, 101-111.
27. Hyakkoku K, Hamanaka J., Tsuruma K., Shimazawa M., Tanaka H., Uematsu S., Akira S., Inagaki N., Nagai H., and, Hara H., (2010) Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 171, 258-267.
28. Iadecola C., and, Anrather J., (2011) The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796-808.
29. Ibrahim A. S., El-Remessy A. B., Matragoon S., Zhang W., Patel Y., Khan S., Al-Gayyar M. M., El-Shishtawy M. M., and, Liou G. I., (2011) Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes 60, 1122-1133.
30. Jack C. S., Arbour N., Manusow J., Montgrain V., Blain M., McCrea E., Shapiro A., and, Antel J. P., (2005) TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 175, 4320-4330.
31. Jehle T., Wingert K., Dimitriu C., Meschede W., Lasseck J., Bach M., and, Lagrèze W. A., (2008) Quantification of ischemic damage in the rat retina: a comparative study using evoked potentials, electroretinography, and histology. Invest. Ophthalmol. Vis. Sci. 49, 1056-1064.
32. Jeong H. K., Jou I., and, Joe E. H., (2010) Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra. Exp. Mol. Med. 42, 823-832.
33. Jin S. X., Zhuang Z. Y., Woolf C. J., and, Ji R. R., (2003) p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 23, 4017-4022.
34. Kaur C., Foulds W. S., and, Ling E. A., (2008) Hypoxia-ischemia and retinal ganglion cell damage. Clin. Ophthalmol. 2, 879-889.
35. Kawai T., and, Akira S., (2007) TLR signaling. Semin. Immunol. 19, 24-32.
36. Ko M. K., Saraswathy S., Parikh J. G., and, Rao N. A., (2011) The role of TLR4 activation in photoreceptor mitochondrial oxidative stress. Invest. Ophthalmol. Vis. Sci. 52, 5824-5835.
37. Koistinaho M., and, Koistinaho J., (2002) Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 40, 175-183.
38. Krady J. K., Basu A., Allen C. M., Xu Y., LaNoue K. F., Gardner T. W., and, Levison S. W., (2005) Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54, 1559-1565.
39. Lai A. Y., and, Todd K. G., (2006) Microglia in cerebral ischemia: molecular actions and interactions. Can. J. Physiol. Pharmacol. 84, 49-59.
40. Lakhan S. E., Kirchgessner A., and, Hofer M., (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 7, 97.
41. Lalancette-Hebert M., Gowing G., Simard A., Weng Y. C., and, Kriz J., (2007) Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 27, 2596-2605.
42. Lambertsen K. L., Clausen B. H., Babcock A. A., et al,. (2009) Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J. Neurosci. 29, 1319-1330.
43. Langmann T., (2007) Microglia activation in retinal degeneration. J. Leukoc. Biol. 81, 1345-1351.
44. Lehnardt S., Schott E., Trimbuch T., Laubisch D., Krueger C., Wulczyn G., Nitsch R., and, Weber J. R., (2008) A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J. Neurosci. 28, 2320-2331.
45. Liang H., Brignole-Baudouin F., Labbé A., Pauly A., Warnet J. M., and, Baudouin C., (2007) LPS-stimulated inflammation and apoptosis in corneal injury models. Mol. Vis. 13, 1169-1180.
46. Lipton P., (1999) Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431-1568.
47. Litvak V., Ramsey S. A., Rust A. G., Zak D. E., Kennedy K. A., Lampano A. E., Nykter M., Shmulevich I., and, Aderem A., (2009) Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat. Immunol. 10, 437-443.
48. Mabuchi T., Kitagawa K., Ohtsuki T., Kuwabara K., Yagita Y., Yanagihara T., Hori M., and, Matsumoto M., (2000) Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 31, 1735-1743.
49. Maitra U., Deng H., Glaros T., Baker B., Capelluto D. G., Li Z., and, Li L., (2012) Molecular mechanisms responsible for the selective and low-grade induction of proinflammatory mediators in murine macrophages by lipopolysaccharide. J. Immunol. 189, 1014-1023.
50. Marsh B., Stevens S. L., Packard A., Gopalan B., Hunter B., Leung P. Y., Harrington C. A., and, Stenzel-Poore M. P., (2009a) Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J. Neurosci. 29, 9839-9849.
51. Marsh B. J., Williams-Karnesky R. L., and, Stenzel-Poore M. P., (2009b) Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 158, 1007-1020.
52. Masland R. H., (2012) The neuronal organization of the retina. Neuron 76, 266-280.
53. Neroev V. V., Zueva M. V., and, Kalamkarov G. R., (2010) Molecular mechanisms of retinal ischemia. Vestn. oftalmol. 126, 59-64.
54. Neufeld A. H., Si Kawai, Das S., Vora S., Gachie E., Connor J. R., and, Manning P. T., (2002) Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase. Exp. Eye Res. 75, 521-528.
55. Obrenovitch T. P., (2008) Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol. Rev. 88, 211-247.
56. Olson J. K., and, Miller S. D., (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173, 3916-3924.
57. Osborne N. N., Casson R. J., Wood J. P., Chidlow G., Graham M., and, Melena J., (2004) Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23, 91-147.
58. Palsson-McDermott E. M., and, O'Neill L. A., (2004) Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113, 153-162.
59. Pang Y., Fan L. W., Zheng B., Campbell L. R., Cai Z., and, Rhodes P. G., (2012) Dexamethasone and betamethasone protect against lipopolysaccharide- induced brain damage in neonatal rats. Pediatr. Res. 71, 552-558.
60. Perlman I., (2009) Testing retinal toxicity of drugs in animal models using electrophysiological and morphological techniques. Doc. Ophthalmol. 118, 3-28.
61. Piao W., Song C., Chen H., Diaz M. A., Wahl L. M., Fitzgerald K. A., Li L., and, Medvedev A. E., (2009) Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling. J. Leukoc. Biol. 86, 863-875.
62. Plane J. M., Shen Y., Pleasure D. E., and, Deng W., (2010) Prospects for minocycline neuroprotection. Arch. Neurol. 67, 1442-1448.
63. Pradillo J. M., Fernandez-Lopez D., Garcia-Yebenes I., Sobrado M., Hurtado O., Moro M. A., and, Lizasoain I., (2009) Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning. J. Neurochem. 109, 287-294.
64. Qin L., Wu X., Block M. L., Liu Y., Breese G. R., Hong J. S., Knapp D. J., and, Crews F. T., (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55, 453-462.
65. Raghavendra V., Tanga F., and, DeLeo J. A., (2003) Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 306, 624-630.
66. Ransohoff R. M., and, Perry V. H., (2009) Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119-145.
67. Rhee K. D., Ruiz A., Duncan J. L., Hauswirth W. W., Lavail M. M., Bok D., and, Yang X. J., (2007) Molecular and cellular alterations induced by sustained expression of ciliary neurotrophic factor in a mouse model of retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 48, 1389-1400.
68. Rosenzweig H. L., Lessov N. S., Henshall D. C., Minami M., Simon R. P., and, Stenzel-Poore M. P., (2004) Endotoxin preconditioning prevents the cellular inflammatory response during ischemic neuroprotection in mice. Stroke 35, 2576-2581.
69. Roth S., Shaikh A. R., Hennelly M. M., Li Q., Bindokas V., and, Graham C. E., (2003) Mitogen-activated protein kinases and retinal ischemia. Invest. Ophthalmol. Vis. Sci. 44, 5383-5395.
70. Sheng J. G., Bora S. H., Xu G., Borchelt D. R., Price D. L., and, Koliatsos V. E., (2003) Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol. Dis. 14, 133-145.
71. Sherry D. M., Mitchell R., Standifer K. M., and, du Plessis B., (2006) Distribution of plasma membrane-associated syntaxins 1 through 4 indicates distinct trafficking functions in the synaptic layers of the mouse retina. BMC Neurosci. 7, 54.
72. Shimazawa M., Yamashima T., Agarwal N., and, Hara H., (2005) Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage. Brain Res. 1053, 185-194.
73. Shpargel K. B., Jalabi W., Jin Y., Dadabayev A., Penn M. S., and, Trapp B. D., (2008) Preconditioning paradigms and pathways in the brain. Cleve. Clin. J. Med. 75, 77-82.
74. Stevens S. L., Leung P. Y., Vartanian K. B., Gopalan B., Yang T., Simon R. P., and, Stenzel-Poore M. P., (2011) Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury. J. Neurosci. 31, 8456-8463.
75. Streit W. J., (2002) Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40, 133-139.
76. Tasaki K., Ruetzler C. A., Ohtsuki T., Martin D., Nawashiro H., and, Hallenbeck J. M., (1997) Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 748, 267-270.
77. Tikka T., Fiebich B. L., Goldsteins G., Keinanen R., and, Koistinaho J., (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21, 2580-2588.
78. Uckermann O., Uhlmann S., Pannicke T., et al,. (2005) Ischemia-reperfusion causes exudative detachment of the rabbit retina. Invest. Ophthalmol. Vis. Sci. 46, 2592-2600.
79. Ueda H., and, Fujita R., (2004) Cell death mode switch from necrosis to apoptosis in brain. Biol. Pharm. Bull. 27, 950-955.
80. Ueda H., Matsunaga H., Uchida H., and, Ueda M., (2010) Prothymosin alpha as robustness molecule against ischemic stress to brain and retina. Ann. N. Y. Acad. Sci. 1194, 20-26.
81. Ueda H., Matsunaga H., and, Halder S. K., (2012) Prothymosin α-a novel endogenous neuroprotective polypeptide against ischemic damages, in Neuropeptides in Neuroprotection and Neuroregeneration (, Nyberg F. J., ed.), pp. 128-143. CRC Press Taylor & Francis Group, Abingdon.
82. Vartanian K. B., and, Stenzel-Poore M., (2010) Toll-like receptor tolerance as a mechanism for neuroprotection. Transl. Stroke Res. 1, 252-260.
83. Vartanian K. B., Stevens S. L., Marsh B. J., Williams-Karnesky R., Lessov N. S., and, Stenzel-Poore M. P., (2011) LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. J. Neuroinflammation 8, 140.
84. Wang A. L., Yu A. C., Lau L. T., Lee C., le Wu M., Zhu X., and, Tso M. O., (2005) Minocycline inhibits LPS-induced retinal microglia activation. Neurochem. Int. 47, 152-158.
85. Wang Y. C., Lin S., and, Yang Q. W., (2011) Toll-like receptors in cerebral ischemic inflammatory injury. J. Neuroinflammation 8, 134.
86. Xiao O., Xie Z. L., Lin B. W., Yin X. F., Pi R. B., and, Zhou S. Y., (2012) Minocycline inhibits alkali burn-induced corneal neovascularization in mice. PLoS ONE 7, e41858.
87. Yang L., Zhu X., and, Tso M., (2007) Minocycline and sulforaphane inhibited lipopolysaccharide-mediated retinal microglial activation. Mol. Vis. 13, 1083-1093.
88. Zeng H. Y., Zhu X. A., Zhang C., Yang L. P., Wu L. M., and, Tso M. O., (2005) Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice. Invest. Ophthalmol. Vis. Sci. 46, 2992-2999. Technology Technology